Fidelity International
JAZZ icon

Fidelity International’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fidelity International’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-58
Closed -$7.51K – 834
2023
Q3 		$7.51K Buy
58
+2
+4% +$266 ﹤0.01% 777
2023
Q2 		$6.94K Buy
56
+22
+65% +$2.96K ﹤0.01% 780
2023
Q1 		$4.97K Buy
34
+28
+467% +$4.14K ﹤0.01% 801
2022
Q4 		$956 Buy
6
+3
+100% +$440 ﹤0.01% 820
2022
Q3 		$0 Buy
+3
New +$456 ﹤0.01% 853
2020
Q1 		– Sell
-239,080
Closed -$35.7M – 895
2019
Q4 		$35.7M Sell
239,080
-511,868
-68% -$69.7M 0.05% 301
2019
Q3 		$96.2M Sell
750,948
-40,004
-5% -$5.36M 0.15% 171
2019
Q2 		$113M Sell
790,952
-14,457
-2% -$1.94M 0.17% 150
2019
Q1 		$115M Sell
805,409
-36,358
-4% -$4.74M 0.18% 146
2018
Q4 		$104M Buy
841,767
+9,067
+1% +$1.35M 0.19% 143
2018
Q3 		$140M Sell
832,700
-17,366
-2% -$2.99M 0.21% 130
2018
Q2 		$146M Sell
850,066
-58,671
-6% -$9.59M 0.22% 122
2018
Q1 		$137M Buy
908,737
+8,935
+1% +$1.31M 0.38% 76
2017
Q4 		$121M Buy
899,802
+7,926
+0.9% +$1.1M 0.34% 88
2017
Q3 		$130M Sell
891,876
-192,328
-18% -$29.1M 0.37% 80
2017
Q2 		$169M Sell
1,084,204
-119,177
-10% -$18.2M 0.49% 55
2017
Q1 		$175M Sell
1,203,381
-21,376
-2% -$2.78M 0.49% 59
2016
Q4 		$134M Sell
1,224,757
-573,729
-32% -$63.9M 0.39% 72
2016
Q3 		$218M Sell
1,798,486
-54
-0% -$7.28K 0.65% 44
2016
Q2 		$254M Buy
1,798,540
+54
+0% +$7.96K 0.81% 35
2016
Q1 		$235M Buy
1,798,486
+832,742
+86% +$104M 0.73% 41
2015
Q4 		$136M Buy
965,744
+125
+0% +$17.3K 0.41% 66
2015
Q3 		$128M Buy
+965,619
New +$166M 0.45% 67

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity International's JAZZ Position: Q4 2023 in Review

Fidelity International sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2023, closing a stake of 58 shares — an estimated $7.51K sold.

Fidelity International first reported a position in JAZZ in Q3 2015 and held it in 23 quarters. The position peaked at $254M in Q2 2016. 499 funds tracked by Wall St. Rank hold JAZZ as of Q4 2023.

  • Fidelity International reported no remaining Jazz Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Fidelity International sold 58 Jazz Pharmaceuticals shares in Q4 2023, an estimated $7.51K.
  • Fidelity International first reported a position in Jazz Pharmaceuticals in Q3 2015 and held it in 23 quarters.
  • Fidelity International's Jazz Pharmaceuticals position peaked at $254M in Q2 2016.
  • 499 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2023.

Based on Fidelity International's 13F filing for Q4 2023, filed 13 Feb 2024.